Synchron CX4/CX5 Clinical Chemistry Analyzer Reage
Nadh Oxidation/Nad Reduction, Alt/Sgpt. 510(k) K883181, from Beckman Instruments, Inc. (Brea, CA). Product code CKA, class 1.
As of Nov 18, 2026, K883181 is an FDA 510(k) held by Beckman Instruments, Inc., substantially equivalent on Sep 19, 1988 after 54 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 54 days
- Recalls: 2
- Cited as a predicate by: 4 devices
Cited as a predicate
4 later 510(k) summaries name this device as a predicate- Synchron LX 20 Clinical Chemistry System, Synchron LX Albumin Reagent, Synchron LX Creatinine Picric Reagent, Synchron LK965240 · Beckman Instruments, Inc. · Mar 10, 1997
- Unicel Dxc Synchron Systems Glucose Reagent (Gluh)K131189 · Beckman Coulter, Inc. · Apr 17, 2014
- Synchron Multi CalibratorK110251 · Beckman Coulter, Inc. · May 25, 2011
- Synchron Systems Phosphorus (Phs) ReagentK041643 · Beckman Coulter, Inc. · Aug 18, 2004
Recalls
Recalls FDA ties to K883181, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record| Aug 10, 2010 | Z-1619-2011The recall was initiated because Cartridge Glucose (GLU) on UniCel DxC and Synchron LX instruments may give falsely high results for moderately hemolysed samples. The Impact: (1) Neonatal samples drawn by lancets are… | Terminated |
| Aug 26, 2009 | Z-1229-2012A recall was initiated because Beckman has confirmed that the standardization of the Immuno Protein Calibrator Set has been re-established to IFCC Reference Preparation for Plasma Proteins, BCR-470 beginning with lot… | Terminated |
Record
- Type
- Traditional
- Received
- Jul 27, 1988
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1030
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files